The Emerging Potential of Pharmacogenetics in Psychiatry

被引:8
作者
Lotrich, Francis E. [1 ]
机构
[1] Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA USA
关键词
EXPRESSION; KCNH2; TRANSCRIPTS; ISOFORM; BRAIN; RISK;
D O I
10.1176/appi.ajp.2012.12040457
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:681 / 683
页数:3
相关论文
共 10 条
[1]   Genetic Variation in KCNH2 Associated With Expression in the Brain of a Unique hERG Isoform Modulates Treatment Response in Patients With Schizophrenia [J].
Apud, Jose A. ;
Zhang, Fengyu ;
Decot, Heather ;
Bigos, Kristin L. ;
Weinberger, Daniel R. .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (07) :725-734
[2]   Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study [J].
Atalar, Fatmahan ;
Acuner, Tufan Tevfik ;
Cine, Naci ;
Oncu, Fatih ;
Yesilbursa, Dogan ;
Ozbek, Ugur ;
Turkcan, Solmaz .
BEHAVIORAL AND BRAIN FUNCTIONS, 2010, 6
[3]   Social Stress Alters Expression of Large Conductance Calcium-Activated Potassium Channel Subunits in Mouse Adrenal Medulla and Pituitary Glands [J].
Chatterjee, O. ;
Taylor, L. A. ;
Ahmed, S. ;
Nagaraj, S. ;
Hall, J. J. ;
Finckbeiner, S. M. ;
Chan, P. S. ;
Suda, N. ;
King, J. T. ;
Zeeman, M. L. ;
McCobb, D. P. .
JOURNAL OF NEUROENDOCRINOLOGY, 2009, 21 (03) :167-176
[4]   Interplay of Genetic Risk Factors (CHRNA5-CHRNA3-CHRNB4) and Cessation Treatments in Smoking Cessation Success [J].
Chen, Li-Shiun ;
Baker, Timothy B. ;
Piper, Megan E. ;
Breslau, Naomi ;
Cannon, Dale S. ;
Doheny, Kimberly F. ;
Gogarten, Stephanie M. ;
Johnson, Eric ;
Saccone, Nancy L. ;
Wang, Jen C. ;
Weiss, Robert B. ;
Goate, Alison M. ;
Bierut, Laura Jean .
AMERICAN JOURNAL OF PSYCHIATRY, 2012, 169 (07) :735-742
[5]   Antipsychotic and antidepressant co-treatment: Effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders [J].
Dell'Aversano, Carmela ;
Tomasetti, Carmine ;
Iasevoli, Felice ;
de Bartolomeis, Andrea .
BRAIN RESEARCH BULLETIN, 2009, 79 (02) :123-129
[6]   ACETYLCHOLINESTERASE INHIBITOR PRETREATMENT ALTERS STRESS-INDUCED EXPRESSION OF ACETYLCHOLINESTERASE TRANSCRIPTS IN THE MOUSE BRAIN [J].
Dori, A. ;
Oriel, S. ;
Livneh, U. ;
Duek, O. ;
Lin, T. ;
Kofman, O. .
NEUROSCIENCE, 2011, 183 :90-98
[7]   A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia [J].
Huffaker, Stephen J. ;
Chen, Jingshan ;
Nicodemus, Kristin K. ;
Sambataro, Fabio ;
Yang, Feng ;
Mattay, Venkata ;
Lipska, Barbara K. ;
Hyde, Thomas M. ;
Song, Jian ;
Rujescu, Dan ;
Giegling, Ina ;
Mayilyan, Karine ;
Proust, Morgan J. ;
Soghoyan, Armen ;
Caforio, Grazia ;
Callicott, Joseph H. ;
Bertolino, Alessandro ;
Meyer-Lindenberg, Andreas ;
Chang, Jay ;
Ji, Yuanyuan ;
Egan, Michael F. ;
Goldberg, Terry E. ;
Kleinman, Joel E. ;
Lu, Bai ;
Weinberger, Daniel R. .
NATURE MEDICINE, 2009, 15 (05) :509-518
[8]   Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials [J].
King, David P. ;
Paciga, Sara ;
Pickering, Eve ;
Benowitz, Neal L. ;
Bierut, Laura J. ;
Conti, David V. ;
Kaprio, Jaakko ;
Lerman, Caryn ;
Park, Peter W. .
NEUROPSYCHOPHARMACOLOGY, 2012, 37 (03) :641-650
[9]   Markers in the 15q24 Nicotinic Receptor Subunit Gene Cluster (CHRNA5-A3-B4) Predict Severity of Nicotine Addiction and Response to Smoking Cessation Therapy [J].
Sarginson, Jane E. ;
Killen, Joel D. ;
Lazzeroni, Laura C. ;
Fortmann, Stephen P. ;
Ryan, Heather S. ;
Schatzberg, Alan F. ;
Murphy, Greer M., Jr. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2011, 156B (03) :275-284
[10]   Antipsychotic-Like Effect of Retigabine [N-(2-Amino-4-(fluorobenzylamino)-phenyl)carbamic Acid Ester], a KCNQ Potassium Channel Opener, via Modulation of Mesolimbic Dopaminergic Neurotransmission [J].
Sotty, Florence ;
Damgaard, Trine ;
Montezinho, Liliana P. ;
Mork, Arne ;
Olsen, Christina K. ;
Bundgaard, Christoffer ;
Husum, Henriette .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03) :951-962